EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features

Posted on by
ACSR Off the Press

The ACSR is proud to share the latest EBV/DLBCL research from the ACSR’s own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! 

EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.

Chapman JR, Bouska AC, Zhang W, Alderuccio JP, Lossos IS, Rimsza LM, Maguire A, Yi S, Chan WC, Vega F, Song JY.Br J Haematol. 2021 Sep;194(5):870-878. doi: 10.1111/bjh.17708. Epub 2021 Jul 17.PMID: 34272731